Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-R-4862 | N-6-Methyl-2-deoxyadenosine CAS No.2002-35-9 | N-6-Methyl-2-deoxyadenosine/CAS No.2002-35-9 is an adenine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | price> |
R-C-3193 | NNC 55-0396 CAS:357400-13-6 | NNC 55-0396, Mibefradil derivative, is a highly selective T-type calcium channel blocker; displays IC50 values of 6.8 and>100μM for inhibition of Cav3.1 T-type channels and HVA currents respectively in INS-1 cells.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4863 | Elacytarabine CAS No.188181-42-2 | Elacytarabine (CP 4055)/CAS No.188181-42-2 is a lipid-conjugated derivative of the nucleoside analog cytarabine. Elacytarabine (CP 4055) is an antineoplastic agent with cytotoxicity in solid tumors. | price> |
R-R-4864 | 5-Amino-5-deoxyadenosine CAS No.14365-44-7 | 5-Amino-5-deoxyadenosine (NH2dAdo; Nsc 238990)/CAS No.14365-44-7 is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | price> |
R-C-3195 | Barnidipine CAS:104713-75-9 | Barnidipine(Mepirodipine)is an L-type calcium antagonist(CaA)with high affinity for[3H]initrendipine binding sites(Ki=0.21nmol/l),has selective action against CaA receptors.Our products are only suitable for scientific research experiments,not for clinical experiments and human body. | price> |
R-R-4865 | 7-Methylguanosine-d3 | 7-Methylguanosine-d3 is the deuterium labeled 7-Methylguanosine. 7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8 ± 7.5 μM. | price> |
R-C-3196 | Funapide CAS:1259933-16-8 | Funapide(TV 45070;XEN402)is a potent Sodium Channel Nav1.7 inhibitor.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4866 | 5-Aza-7-deazaguanine CAS No.67410-64-4 | 5-Aza-7-deazaguanine/CAS No.67410-64-4 is a substrate for wild-type (WT) E. coli purine nucleoside phosphorylase and its Ser90Ala mutant in the synthesis of base-modified nucleosides. | price> |
R-C-3197 | ICA-121431 | ICA-121431 is a potent and selective inhibitor of human NaV1.3 and NaV1.1 channels (IC50 values are 13 and 23nM respectively).Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4867 | N6-Etheno 2-deoxyadenosine CAS No.68498-25-9 | N6-Etheno 2-deoxyadenosine/CAS No.68498-25-9 is a reactive oxygen species (ROS)/reactive nitrogen species (RNS)-induced DNA oxidation product, used as a biomarker to evaluate chronic inflammation and lipid peroxidation in animal or human tissues. | price> |
R-C-3198 | PF-05089771 CAS:1235403-62-9 | PF-05089771 is a Selective Nav1.7 Inhibitor(IC50=11nM)that interacts with the voltage-sensor domain(VSD)of domain IV,Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4868 | CCPA CAS No.37739-05-2 | CCPA (2-Chloro-N6-cyclopentyladenosine)/CAS No.37739-05-2 is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | price> |
R-C-3199 | Raxatrigine (GSK1014802) CAS:934240-30-9 | Raxatrigine (GSK1014802) is a novel sodium channel blocker and is an effective anticonvulsant agent. In rats, GSK1014802 (20 - 80 mg/kg p.o.) attenuated the deficit in reversal learning induced by phencyclidine (PCP) in a dose-dependent way, which suggested the potential of GSK1014802 in the treatment of cognitive symptoms of schizophrenia. GSK2 was also a potent inhibitor of human MAO-B with pIC50 value of 7.96 but did not inhibit human MAO-A.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4869 | Arabinosylhypoxanthine CAS No.7013-16-3 | Arabinosylhypoxanthine/CAS No.7013-16-3 is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | price> |
R-C-3200 | Cisapride (R 51619) CAS:81098-60-4 | Cisapride(R 51619,Kaudalit, Kinestase,Prepulsid,Presid,Pridesia,Propulsid) is a nonselective 5-HT4 receptor agonist with gastroprokinetic effects.Our products are only suitable for scientific research experiments,not for clinical experiments and human body. | price> |
R-R-4870 | 1-Methylinosine-d3 | 1-Methylinosine-d3 is the deuterium labeled 1-Methylinosine. 1-Methylinosine is a modified nucleotide found at position 37 in tRNA 3 to the anticodon of eukaryotic tRNA. | price> |
R-C-3201 | VU591 CAS:1222810-74-3 | VU591 is a potent, selective renal outer medullary potassium channel (ROMK or Kir1.1) inhibitor, with an IC50 of 0.24μM.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4871 | 2-O,4-C-Methyleneuridine CAS No.200435-92-3 | 2-O,4-C-Methyleneuridine (Compound 15a)/CAS No.200435-92-3 is a bicyclic nucleoside. | price> |
R-C-3202 | NS 309 CAS:18711-16-5 | NS309 is a potent and selective activator of human Ca2+ -activated K+ channels of SK and IK types with an EC50 of 150 nM for hSK3 channel,and displays no activity at BK channels. Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4872 | 4-Sulfocalix[8]arene Hydrate CAS 137407-62-6 | 4-Sulfocalix[8]arene Hydrate/CAS 137407-62-6 is a polymeric matrix of sulfonated arenes that can be used to deliver enzymes for the treatment of diabetes. It has been shown to increase glucose uptake and decrease glycosylation of proteins, leading to improved insulin sensitivity in diabetic patients. 4-Sulfocalix[8]arene Hydrate is stable in the presence of strong acids and bases, allowing it to be administered orally. The diameter of the polymer can be tuned by changing the ratio between hydroxyl groups and sulfonated arenes. This property allows researchers to control the duration of enzyme release and improve its targeting properties. The polymer has also been shown to bind with fluorescence spectrometry, which may make it useful for detecting chemical reactions or identifying target tissue. | price> |